NCT03045991

Brief Summary

The purpose of this study is to determine the treatment effects of sequential combination of aerobic exercise and cognitive training on cognitive function, physiological markers, daily function, physical function, social participation and quality of life in stroke patients with cognitive decline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 8, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2019

Completed
Last Updated

February 5, 2020

Status Verified

February 1, 2020

Enrollment Period

3.1 years

First QC Date

December 12, 2016

Last Update Submit

February 4, 2020

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change scores of Montreal Cognitive Assessment (MoCA)

    The MoCA will be used to assess general cognitive functions. It examines several cognitive domains with a total score of 30

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • Change scores of Wechsler Memory Scale - Third Edition (WMS-III)

    The WMS-III is a standardized and reliable neuropsychological examination tool designed to evaluate visuospatial and memory functions

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)

    The WAIS-III is developed to measure an individual's intelligence level. It includes tests that evaluate cognitive functions in verbal comprehension, working memory, perceptual organization, and processing speed

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • Change scores of Useful Field of View (UFOV)

    The UFOV assessment is a computer-based visual test containing three subtests: visuomotor processing speed, divided attention, and selective attention.

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • Change scores of Stroop Color-Word test

    The Stroop Color-Word assesses the abilities of selective attention, inhibition and executive function. The participants will be tested under congruent and incongruent conditions.

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • Change scores of Dual-task test

    The dual-task test evaluates the ability to shift attention between one task and another. Participants will perform the box and block test (BBT) while doing secondary cognitive tasks while sitting. Participants will perform BBT by affected and less affected hand.

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

Secondary Outcomes (23)

  • Change scores of serum BDNF level

    Baseline, posttest (an expected average of 3 months)

  • Change scores of Antioxidative marker

    Baseline, posttest (an expected average of 3 months)

  • Change scores of Glucose indicator

    Baseline, posttest (an expected average of 3 months)

  • Change scores of Plasma lipid level

    Baseline, posttest (an expected average of 3 months)

  • Change scores of Functional Independence Measure (FIM)

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • +18 more secondary outcomes

Study Arms (2)

sequential training group (SEQ)

EXPERIMENTAL

The sequential training group (SEQ) will first receive 30-minutes aerobic exercise training followed by 30-minutes computerized cognitive training. All participants will receive a training session for 60 minutes per day, three days per week for 12 weeks, a total of 36 training sessions. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.

Behavioral: aerobic exercise trainingBehavioral: cognitive training

control intervention group (CI)

ACTIVE COMPARATOR

The control intervention group (CI) will receive a control training session for 60 minutes per day, three days per week for 12 weeks, a total of 36 training sessions. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.

Behavioral: control training

Interventions

The aerobic exercise program using progressive resistive stationary bicycle training which will contain warm-up, resistive physical exercise, and cool-down. The training resistance will increase with improvement of participants' performance.

sequential training group (SEQ)

The control training program will receive 30 minutes non-aerobic exercise training, including stretching muscle skills, joint mobility exercises; in addition to one 30-minute session of unstructured mental activities, such as reading books or reading educational films.

control intervention group (CI)

The computerized cognitive training program will be implemented with the brainHQ to target abilities of visuospatial processing, attention, memory, and executive function. The level of the training program will become more difficult with progress in participants' targeted cognitive abilities.

sequential training group (SEQ)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
  • MMSE score ≥ 19,MoCA\<26,able to follow the study instruction
  • Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
  • Adequate cardiopulmonary function to perform aerobic exercise
  • Able to walk with or without assistive devices

You may not qualify if:

  • Unstable medical history (e.g., recent myocardial infarction) that might limit participation
  • Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
  • Current participation in another interventional trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Chiayi Chang Gung Memorial Hospital

Chiayi City, 613, Taiwan

Location

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, 83301, Taiwan

Location

Keeling Chang Gung Memorial Hospital

Keelung, 204, Taiwan

Location

Taipei Chang Gung Memorial Hospital

Taipei, 105, Taiwan

Location

Taoyuan Chang Gung Memorial Hospital

Taoyuan, 333, Taiwan

Location

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

Related Publications (1)

  • Yeh TT, Chang KC, Wu CY. The Active Ingredient of Cognitive Restoration: A Multicenter Randomized Controlled Trial of Sequential Combination of Aerobic Exercise and Computer-Based Cognitive Training in Stroke Survivors With Cognitive Decline. Arch Phys Med Rehabil. 2019 May;100(5):821-827. doi: 10.1016/j.apmr.2018.12.020. Epub 2019 Jan 9.

MeSH Terms

Interventions

Cognitive Training

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Ching-Yi Wu, ScD

    Chang Gung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2016

First Posted

February 8, 2017

Study Start

September 1, 2016

Primary Completion

October 16, 2019

Study Completion

November 20, 2019

Last Updated

February 5, 2020

Record last verified: 2020-02

Locations